Clinical Trials · NCT03379974

Exercise Versus DDAVP in Patients With Mild Hemophilia A

Name: Exercise Versus DDAVP in Patients With Mild Hemophilia A
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Desmopressin

Phase: Phase 4
Recruitment status: Completed
Sponsor: Nationwide Children's Hospital
Enrollment: 32
Start date: Jul 2018
Locations: 4 sites, United States
Primary endpoint: •Factor 8 level after exercise [ Time Frame: Baseline, 30 min post intervention #1, 30 min post intervention #2 and 90 minute post intervention #2

View Desmopressin compound reference